Diltiazem Found to Be Better than Metoprolol in Heart Rate Reduction for Atrial Fibrillation in Heart Failure

Hamidi, Arzo PharmD, BCCCP

Clinical Pharmacy Specialist, Adult Critical Care, Rush University Medical Center, Chicago

Critical Care Alert 30(2):p 13-14, May 2023.

SYNOPSIS: In patients with atrial fibrillation and heart failure, intravenous diltiazem results in greater heart rate reduction than metoprolol with a similar safety profile, but further research is needed in this patient population.

SOURCE: Compagner CT, Wysocki CR, Reich EK, et al. Intravenous metoprolol versus diltiazem for atrial fibrillation with concomitant heart failure. Am J Emerg Med 2022;62:49-54.